Evidence map›Paper›PMID 40537467›Full record

ArticleNature communications2025

Improving human papillomavirus vaccination coverage in France: a need to act but not to rush.

Nathalie Thilly, Morgane Michel, Sébastien Bruel, Amandine Gagneux-Brunon, Serge Gilberg, Anne-Sophie Banaszuk, Aurélie Gauchet, Bruno Giraudeau, Judith E Mueller, Aurélie Bocquier

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nathalie ThillyUniversité de Lorraine, Inserm, INSPIIRE, Nancy, France. nathalie.thilly@univ-lorraine.fr.ORCID http://orcid.org/0009-0006-9665-2936
Morgane MichelUniversité Paris Cité, ECEVE, UMR 1123, Inserm, Paris, France.ORCID http://orcid.org/0000-0001-6090-8211
Sébastien BruelDépartement de Médecine Générale, Faculté de Médecine Jacques Lisfranc, Université Saint-Etienne-Lyon, Saint-Etienne, France.ORCID http://orcid.org/0000-0001-7413-5248
Amandine Gagneux-BrunonCIC-1408 Vaccinologie, CHU de Saint-Etienne, Saint-Etienne, France.ORCID http://orcid.org/0000-0002-0892-2187
Serge GilbergUniversité Paris Cité, Département de Médecine Générale, Paris, France.ORCID http://orcid.org/0009-0009-2852-7385
Anne-Sophie BanaszukCentre Régional de Coordination des Dépistages des cancers-Pays de la Loire, Angers, France.
Aurélie GauchetUniversité Savoie Mont Blanc, Université Grenoble Alpes, LIP/PC2S, Grenoble, France.ORCID http://orcid.org/0000-0003-1144-403X
Bruno GiraudeauUniversité de Tours, Université de Nantes, SPHERE U1246, Inserm, Tours, France.ORCID http://orcid.org/0000-0003-3031-8258
Judith E MuellerInstitut Pasteur, Université Paris Cité, Unité d'Epidémiologie des Maladies Emergentes, Paris, France.ORCID http://orcid.org/0000-0003-0797-9971
Aurélie BocquierUniversité de Lorraine, Inserm, INSPIIRE, Nancy, France.ORCID http://orcid.org/0000-0002-0192-8447

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40537467
PMCPMC12179273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.